Prescription drugs are a multi-billion dollar industry. States like Maine, under pressure from rising health care costs, are turning a critical eye on pharmaceutical marketing, questioning its impact on patient care, health care quality and costs. In this issue, we explore basic reforms to rein in costs
By Jennifer Reck